It's an all change from purely theoretical and lab to talking to potential customers and finding gaps in the market that AXE can fill. This change together with a stream of announcements to market is all just what the doctor ordered. Personally, I'd rather sit back and watch the SP reflect these than talk here on HC now lol. Seriously far too much to read and respond to in a timely way for me, so am super cheerful about the state of affairs.
Could not be more pleased about the board taking steps to land the tech potential with Simon as CTO. Case in point, the CNOs, carbon nano onions. How we loved those things, but Simon coming on board helped us to pivot to the films which are also nanomaterial but much better at scaling and also able to be manufactured at much reduced costs. No longer do we indulge in expensive science experiments. Now we have enough R&D to take some smart and calculated leaps. Now we are in a much better position to offer products at the right price points. Icing on the cake is that AXE can use these same films with some tweaks for other use cases. Let's get the TMRs locked in though.
News of getting a partner in the US to work through the bio chip FDA approvals and testing will be major and will provide some good catalysts for price. Let's hope some news is forthcoming soon!
AXE Price at posting:
32.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)